WESPAC Advisors’s Varian Medical Systems, Inc. VAR Stock Holding History

WESPAC Advisors’s Portfolio VAR Stock Details VAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,746	Closed	-$247K	–	150
2019 Q1	$247K	Buy	+1,746	New	+$229K	0.17%	106

Other funds holding VAR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WESPAC Advisors's VAR Position: Q2 2019 in Review

WESPAC Advisors sold out of Varian Medical Systems, Inc. (VAR) in Q2 2019, closing a stake of 1,746 shares — an estimated $247K sold.

WESPAC Advisors first reported a position in VAR in Q1 2019 and held it in 1 quarter. The position peaked at $247K in Q1 2019. 585 funds tracked by Wall St. Rank hold VAR as of Q2 2019.

WESPAC Advisors reported no remaining Varian Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
WESPAC Advisors sold 1,746 Varian Medical Systems, Inc. shares in Q2 2019, an estimated $247K.
WESPAC Advisors first reported a position in Varian Medical Systems, Inc. in Q1 2019 and held it in 1 quarter.
WESPAC Advisors's Varian Medical Systems, Inc. position peaked at $247K in Q1 2019.
585 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2019.

Based on WESPAC Advisors's 13F filing for Q2 2019, filed 23 Jul 2019.